Given that the above markers are potential biomarkers of PD‐1/PD‐L1 blockade efficacy, we aimed to characterize the distributions of these biomarkers in more than 1000 Chinese patients with cancer using exome profiling data. The gene discussed is CD274; the disease is cancer.